U.S., Sept. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07182370) titled 'Polyphenol Metabolism and Personalized Nutrition in Menopause (PolyPause).' on Sept. 02.
Brief Summary: The study aims to evaluate the role of the gut microbiome and phageome in explaining interindividual variability in the metabolic response to polyphenol-rich nutraceuticals among menopausal women. Insights from this research will support the development of personalized nutrition strategies to improve quality of life and reduce cardiovascular disease (CVD) risk during menopause.
Study Start Date: Jan. 15, 2024
Study Type: INTERVENTIONAL
Condition:
Menopause Related Conditions
Cardiovascular Risk
Intervention:
DIETARY_SUPPLEM...